Kathleen Mullane to Immunogenicity, Vaccine
This is a "connection" page, showing publications Kathleen Mullane has written about Immunogenicity, Vaccine.
Connection Strength
0.057
-
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM). Clin Infect Dis. 2023 10 13; 77(8):1102-1110.
Score: 0.057